Actively Recruiting

Phase 1
Phase 2
Age: 1Month - 12Years
All Genders
NCT06949904

The Role of Melatonin as an Adjuvant Therapy in Childhood Pneumonia

Led by Mian Muhammad Hassan Ahmed · Updated on 2025-04-29

60

Participants Needed

1

Research Sites

35 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this study is to compare the mean length of hospital stay between children with pneumonia receiving melatonin as an adjuvant therapy and those receiving standard of care alone. The hypothesis is that combining oral melatonin with standard treatment can reduce the length of hospital stay as compared to standard of care alone. The control group will receive standard treatment (antibiotic) while the intervention group will receive standard treatment plus melatonin for 14 days.

CONDITIONS

Official Title

The Role of Melatonin as an Adjuvant Therapy in Childhood Pneumonia

Who Can Participate

Age: 1Month - 12Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 1 month and 12 years
  • Both boys and girls
  • Diagnosed with pneumonia or severe pneumonia based on WHO definition
Not Eligible

You will not qualify if you...

  • Hospitalized within 14 days before the study
  • Known exposure to tuberculosis
  • Active varicella or herpes simplex infection
  • Allergy to melatonin or study medication
  • Currently taking melatonin
  • Any other acute illness requiring antibiotics not related to pneumonia
  • Conditions like galactose intolerance, lactase deficiency, or glucose-galactose malabsorption
  • Serious lung, heart, immune, liver, endocrine, neurological, or psychiatric disease

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Pakistan Institute of Medical Sciences

Islamabad, Islamabad, Pakistan, 44000

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here